Ephedra/ephedrine: Cardiovascular and CNS effects

CMAJ. Canadian Medical Association Journal

Volumn 166, Issue 5, 2002, Pages 633-

  Wooltorton, Eric ^a   Sibbald, Barbara ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; EPHEDRA EXTRACT; EPHEDRINE; METHYLEPHEDRINE; NORPSEUDOEPHEDRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE;

ANXIETY NEUROSIS; CANADA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CORONARY ARTERY CONSTRICTION; DRUG ACTIVITY; DRUG APPROVAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; EPHEDRA; FLUSHING; FOOD AND DRUG ADMINISTRATION; HEADACHE; HEALTH HAZARD; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE REFRACTORY PERIOD; HUMAN; HYPERTENSION; INSOMNIA; NOSE CONGESTION; PSYCHOSIS; RISK FACTOR; SEIZURE; SHORT SURVEY; STROKE; SUBARACHNOID HEMORRHAGE; SUICIDE; THROMBOCYTE ACTIVATION; TREATMENT CONTRAINDICATION; TREMOR; VASOSPASM;

EID: 0036205406     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids
2. Voluntary recall of ephedra products not enough, MD says